Account
Insider Insights
30.01.2024
New MHRA procedure can accelerate patient access t...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...

Read more
News
16.11.2022
PMA Insights: Week 46 SPECIAL EDITION ISPOR 2022 R...

We summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...

Read more
Articles
25.10.2022
How is International Reference Pricing used within...

We discuss the advantages and disadvantages of using international reference pricing for consistent ...

Read more
Publications
12.10.2022
ISPOR 2022: Is International Reference Pricing App...

In our research, we determine how consistently IRP is applied in pharmaceutical price re-evaluation ...

Read more
Insider Insights
18.05.2022
Access to new treatments could extend lives

The research looks at the benefits for 13 medicines across four treatment areas.

Read more
Insider Insights
09.02.2022
CMA fines firms 35 million

The actions of the companies meant that from December 2013 to December 2017, the price paid by the N...

Read more
Articles
12.07.2021
EU & UK Reference Pricing Guide

The EU is known for the variety of market access rules its member states impose. We’re here to gui...

Read more
Articles
20.05.2020
International Reference Pricing

IRP is a pricing mechanism where the price of a drug in one country is set or adjusted in relation t...

Read more
Articles
14.02.2020
Drug price reductions in the US

Prescription drug prices in the US rank among the highest in the world and the US spent $1220 on ph...

Read more
Articles
26.09.2019
New reference pricing rules for Greece 2019

Medicine prices in Greece are set by the IRP. IRP is the process of using the prices in other countr...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.